Drug indexes split as Depomed tumbles

Shares of Depomed slide on news that partner Abbott Laboratories might be balking at launching a new pain reliever.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.